Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HK2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
HK2 is a gene implicated in neurodegeneration research. Key relationships include: activates, inhibits, therapeutic target. Associated with ALS, Aging, Als. Connected to 408 entities in the SciDEX knowledge graph.
| Gene Symbol | HK2 |
| Full Name | Hexokinase 2 |
| Chromosome | 2p12 |
| Protein Type | Enzyme |
| Target Class | Enzyme |
| Function | Small molecule inhibitor of glucose phosphorylation |
| Mechanism of Action | Small molecule inhibitor of glucose phosphorylation |
| Primary Expression | Brain, Muscle, Fat |
| Druggability | Low (0.38) |
| Clinical Stage | Phase III |
| Pathways | Akt, Apoptosis, Epigenetic, Erk Signaling, Glucose Metabolism |
| UniProt ID | P19367 |
| NCBI Gene ID | 3099 |
| Ensembl ID | ENSG00000149718 |
| GeneCards | HK2 |
| Human Protein Atlas | HK2 |
| Associated Diseases | ALS, Acute Kidney Injury, Alzheimer, Alzheimer's disease, Cancer |
| Known Drugs/Compounds | ADUCANUMAB, aducanumab |
| Interactions | MYC, FASN, HK1, AKT, SRC, SPR |
| SciDEX Target | View Target Profile (10 clinical trials) |
| SciDEX Hypotheses | Metabolic Switch Targeting for A1→A2 Repolarizatio Metabolic Reprogramming via Microglial Glycolysis |
| KG Connections | 810 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
HK2["HK2"] -->|"associated"| neurodegeneration["neurodegeneration"]
HK2["HK2"] -->|"co discussed"| MIRO1["MIRO1"]
HK2["HK2"] -->|"co discussed"| P2RY1["P2RY1"]
HK2["HK2"] -->|"co discussed"| SOAT1["SOAT1"]
HK2["HK2"] -->|"co discussed"| KCNK2["KCNK2"]
HK2["HK2"] -->|"co discussed"| TET2["TET2"]
BMAL1["BMAL1"] -->|"co discussed"| HK2["HK2"]
style HK2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | activates | disease | 1.00 |
| Glycolysis | activates | pathway | 1.00 |
| CANCER | activates | gene | 1.00 |
| VDAC | interacts_with | protein | 0.95 |
| Metabolic Stress | mediates | process | 0.95 |
| Histone Lactylation | mediates | mechanism | 0.95 |
| Hepatic Stellate Cell Activation | associated_with | process | 0.95 |
| glycolysis | drives | pathway | 0.95 |
| Ubiquitin-Proteasome System | associated_with | pathway | 0.95 |
| Tumor | activates | disease | 0.95 |
| GLYCOLYSIS | involved_in | entity | 0.95 |
| MITOCHONDRIAL FUNCTION | modulates | entity | 0.92 |
| mitophagy | regulates | process | 0.92 |
| Histone Lactylation | regulates | process | 0.90 |
| glucose metabolism | involved_in | process | 0.90 |
| Glycolysis | involved_in | process | 0.90 |
| NEURODEGENERATION | therapeutic_target | entity | 0.90 |
| MACROPHAGE | expressed_in | entity | 0.90 |
| Glycolysis | upregulates | pathway | 0.90 |
| AKT | activates | gene | 0.90 |
| PI3K | activates | gene | 0.90 |
| GENES | activates | gene | 0.90 |
| Pi3K/Akt | activates | pathway | 0.90 |
| MASLD | associated_with | disease | 0.88 |
| Inflammation | upregulates | process | 0.88 |
| Liver Macrophages | expressed_in | cell_type | 0.85 |
| Inflammation Burden | regulates | phenotype | 0.85 |
| Renal Ischemia-Reperfusion Injury | contributes_to | disease | 0.85 |
| Lactate Production | regulates | process | 0.85 |
| Gene Expression | regulates | process | 0.85 |
| Lactate | associated_with | compound | 0.85 |
| Acute Kidney Injury | associated_with | disease | 0.85 |
| Metabolic Dysfunction-Associated Fatty Liver Disease | implicated_in | disease | 0.85 |
| Tumor Metastasis | involved_in | phenotype | 0.85 |
| Als | activates | disease | 0.85 |
| Tumor | associated_with | disease | 0.85 |
| Cancer | inhibits | disease | 0.85 |
| NEUROINFLAMMATION | mediates | entity | 0.85 |
| NEURODEGENERATION | associated_with | entity | 0.85 |
| inflammation | promotes | process | 0.85 |
| Aerobic Glycolysis | involved_in | process | 0.80 |
| Lactate | regulates | compound | 0.80 |
| Acute Kidney Injury | contributes_to | disease | 0.80 |
| Renal Function | regulates | phenotype | 0.80 |
| glucose-dependent signaling | mediates | process | 0.80 |
| AGING | associated_with | entity | 0.80 |
| glycolysis | rate_limits | pathway | 0.80 |
| Mtor | activates | pathway | 0.80 |
| Proximal Tubular Cells | expressed_in | cell_type | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Phds | degrades | drug | 0.95 |
| AST-120 | downregulates | drug | 0.90 |
| PINK1 | interacts_with | gene | 0.90 |
| Pi3K/Akt Pathway | phosphorylates | pathway | 0.90 |
| RGFP966 | downregulates | drug | 0.90 |
| Retinitis Pigmentosa progression | downregulates | phenotype | 0.90 |
| Glucose Metabolism | regulates | process | 0.90 |
| Chnds | degrades | drug | 0.90 |
| PI3K/AKT | phosphorylates | pathway | 0.90 |
| h-a1b56d74 | targets_gene | hypothesis | 0.90 |
| h-38292315 | targets_gene | hypothesis | 0.90 |
| h-var-ac50d1e3d1 | targets_gene | hypothesis | 0.90 |
| HIF1A | upregulates | gene | 0.88 |
| STAT3 | upstream_of | protein | 0.85 |
| Mdivi-1 | downregulates | drug | 0.85 |
| STAT3 | regulates | protein | 0.80 |
| h-a1b56d74 | targets | hypothesis | 0.80 |
| h-38292315 | targets | hypothesis | 0.80 |
| KLF14 | inhibits | gene | 0.80 |
| H3K18 Lactylation | upregulates | process | 0.80 |
| glucose metabolism | modulates | process | 0.80 |
| PAL | upregulates | compound | 0.80 |
| glucose metabolism | activates | process | 0.80 |
| PTEN | activates | gene | 0.80 |
| STING | activates | gene | 0.70 |
| CANCER | inhibits | gene | 0.70 |
| MITOPHAGY | activates | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| ASTROCYTE | activates | cell_type | 0.70 |
| HDAC3 | regulates | gene | 0.65 |
| LACTATE | inhibits | phenotype | 0.65 |
| LACTATE | treats | phenotype | 0.65 |
| ROS | treats | phenotype | 0.65 |
| FASN | activates | gene | 0.60 |
| SRC | activates | gene | 0.60 |
| HK1 | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| HK1 | interacts_with | gene | 0.60 |
| TNF | inhibits | gene | 0.60 |
| SPR | inhibits | gene | 0.60 |
| TFAM | inhibits | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| PI3K | regulates | gene | 0.60 |
| AKT | regulates | gene | 0.60 |
| PINK1 | activates | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| FASN | associated_with | gene | 0.60 |
| LGMN | interacts_with | gene | 0.60 |
| PPP1CB | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Metabolic Switch Targeting for A1→A2 Repolarization | 0.481 | neurodegeneration | Astrocyte reactivity subtypes in neurode |
| Metabolic Reprogramming via Microglial Glycolysis Inhibition | 0.385 | neurodegeneration | Synaptic pruning by microglia in early A |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.503
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.554
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Bergenin attenuates traumatic brain injury via inhibition of microglial PFKFB3-d [PMID:41520557] | Sun B, Zhang A, Feng S, Jamali AW, Jia Z | Int Immunopharmacol | 2026 | 1 |
| HK1 and HK2 Beyond Glycolysis: Mitochondrial Interactions and Dual Roles in Meta [PMID:41387352] | Pesce NA, Seminara G, Giarrusso G, Tomas | Adv Biol (Weinh) | 2026 | 1 |
| Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative [PMID:39987285] | Fang M, Zhou Y, He K, Lu Y, Tao F, Huang | Mol Neurobiol | 2025 | 1 |
| Deficiency of Microglial Hv1 Protects Against Lipopolysaccharide-Induced Neuroin [PMID:40911376] | Sun L, Wang X, Guan S, Zhang P, Chen D, | FASEB J | 2025 | 1 |
| Hexokinase 2-mediated metabolic stress and inflammation burden of liver macropha [PMID:40014451] | Li J, Chen X, Song S, Jiang W, Geng T, W | Cell Rep | 2025 | 1 |
| The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. [PMID:38904014] | Fontana F, Giannitti G, Marchesi S, Limo | Int J Biol Sci | 2024 | 1 |
| AST-120 alleviates renal ischemia-reperfusion injury by inhibiting HK2-mediated [PMID:39217289] | Zhou J, Zhang J, Xu F, Gao H, Wang L, Zh | Mol Med | 2024 | 1 |
| Hexokinase 2-mediated gene expression via histone lactylation is required for he [PMID:37463576] | Rho H, Terry AR, Chronis C, Hay N | Cell Metab | 2023 | 1 |
| Metabolic phenotype of bladder cancer. [PMID:26975021] | Massari F, Ciccarese C, Santoni M, Iacov | Cancer Treat Rev | 2016 | 1 |
| Crosstalk Between [PMID:41899603] | ["Ren Y", "Tang D", "Ding X", "He M"] | Cancers | 2026 | 0 |
| Suoquan Yishen formula attenuates ectopic lipid deposition in diabetic kidney di [PMID:41461331] | Wang J, Lin N, Li X, Ma T, Yuan Y et al. | J Ethnopharmacol | 2026 | 0 |
| Yi-Shen-Hua-Shi granules ameliorate renal injury via PPARγ-Klotho-mediated metab [PMID:41475627] | Gao HZ, Sun LM, Hu D, Li J, Chen CL et a | J Ethnopharmacol | 2026 | 0 |
| Bisphenol A Promotes Ovarian Cancer Proliferation and Migration through the HK2/ [PMID:41885081] | Xie X, Zhang Y, Li Y, Yan Q, Dong J et a | J Agric Food Chem | 2026 | 0 |
| Targeting SAT1 alleviates high glucose-induced tubular ferroptosis and fibrosis: [PMID:41936633] | Tang Y, Wang S, Wang Y, Zhang T, Liu Y e | Histochem Cell Biol | 2026 | 0 |
| SIRT1-regulated mitophagy mitigates lipotoxicity-induced ferroptosis in diabetic [PMID:41945160] | Jian Y, Zeng Y, Wang Z, Zhou X, Zhang H | Apoptosis | 2026 | 0 |
| Nuclear hexokinase 2 couples hyperglycemia to MYC-driven glycolytic and stemness [PMID:41951587] | Liu S, Liu X, Liu G, Wang Z, Li C et al. | Cell Death Dis | 2026 | 0 |
| Resveratrol inhibits renal ischemia and reperfusion injury in diabetes via reduc [PMID:41958068] | Gong D, Chen X, Dong Z, Chen H, Liu Z | Ren Fail | 2026 | 0 |
| Sirtuin 5-mediated desuccinylation of PRDX6 inhibits ferroptosis and alleviates [PMID:41960638] | Lin W, Dong C, Jiang Q, Lou Y, Wang L et | Redox Rep | 2026 | 0 |
| Modulation of Aerobic Glycolysis Genes During the Progression of Retinitis Pigme [PMID:41569027] | ["Adani E", "Villa Vasquez S", "Lovino M | Investigative ophthalmology & | 2026 | 0 |
| Duzhong-Gegen formula ameliorated hyperuricemia by enhancing renal uric acid exc [PMID:41905095] | Wang L, Gan Y, Huang J, Long L, Li S, Wa | Phytomedicine : international | 2026 | 0 |